Real-time enrollment status for this alpha1-antitrypsin deficiency clinical trial
Current Status
Recruiting
Checked: September 1, 2026 at 9:42 PM UTC
| NCT Number | NCT06512454 |
| Recruiting Status | Recruiting |
| Condition | Alpha1-Antitrypsin Deficiency |
| Phase | Clinical Trial |
| Target Enrollment | 500 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Takeda |
| Last Updated on CT.gov | July 24, 2026 (Jul 24, 2026) |
As of September 1, 2026: Clinical trial NCT06512454 is currently recruiting participants. This clinical trial study for alpha1-antitrypsin deficiency is actively seeking new participants at 3 locations across the United States. The study is sponsored by Takeda. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06512454 is actively recruiting participants as of September 1, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06512454 was last updated Jul 24, 2026 (July 24, 2026). HelloStudys verifies this status automatically.